![Mark Sard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Sard
Directeur/Membre du Conseil chez
LIRUM THERAPEUTICS, INC.
Profil
Mark Sard is the founder.
He founded Frontier Equities VC LLC in 2011 as a Principal.
He is currently working as a Director at Lirum Therapeutics, Inc. since 2022.
Previously, he worked as a Director at Stemline Therapeutics, Inc. from 2018 to 2020.
Mr. Sard completed his undergraduate degree at the University of Pennsylvania.
Postes actifs de Mark Sard
| Sociétés | Poste | Début |
|---|---|---|
| LIRUM THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2022 |
Frontier Equities VC LLC
 Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors. | Fondateur | 01/01/2011 |
Anciens postes connus de Mark Sard
| Sociétés | Poste | Fin |
|---|---|---|
| STEMLINE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/06/2020 |
Formation de Mark Sard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frontier Equities VC LLC
Frontier Equities VC LLC Investment ManagersFinance Frontier Equities seeks investment opportunities in early to mid-stage companies located in United States. The firm focuses across a wide array of sectors. | Finance |
Lirum Therapeutics, Inc.
 Lirum Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that focuses on the treatment of debilitating diseases | Health Technology |
